• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Gorilla Technology Group Shares Are Trading Lower By 25%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    9/20/23 2:10:56 PM ET
    $ADD
    $AGRI
    $ASST
    $ATRA
    Engineering & Construction
    Consumer Discretionary
    Metal Fabrications
    Industrials
    Get the next $ADD alert in real time by email

    Gainers

    MSP Recovery, Inc. (NASDAQ:LIFW) shares jumped 104.5% to $0.1916.

    Digital Transformation Opportunities Corp. (NASDAQ:DTOC) rose 100.7% to $27.50 after dipping 53% on Tuesday.

    Bluejay Diagnostics, Inc. (NASDAQ:BJDX) gained 56.4% to $4.8499. Bluejay Diagnostics, last month, announced a $1.59 million registered direct offering of 216,000 shares at $7.365 per share.

    Fresh Tracks Therapeutics, Inc. (NASDAQ:FRTX) shares gained 50% to $0.8705 after the company announced its Board of Directors has approved a plan of liquidation and dissolution.

    AgriFORCE Growing Systems Ltd. (NASDAQ:AGRI) rose 38% to $0.1478.

    TransCode Therapeutics, Inc. (NASDAQ:RNAZ) shares gained 32.9% to $0.6974 after falling 10% on Tuesday.

    Evaxion Biotech A/S (NASDAQ:EVAX) gained 29.2% to $0.6201. Evaxion partnered with pharmaceutical company Afrigen Biologics to develop novel mRNA vaccine against gonorrhoea.

    Steelcase Inc. (NYSE:SCS) jumped 27.3% to $11.22. Steelcase reported better-than-expected results for its second quarter.

    Solowin Holdings (NASDAQ:SWIN) gained 26% to $3.08.

    Cambridge Bancorp (NASDAQ:CATC) rose 23.9% to $60.22 after the company announced it entered into a definitive agreement to merge with Eastern Bankshares.

    Histogen Inc. (NASDAQ:HSTO) shares rose 23.4% to $0.4873. Histogen shares fell 40% on Tuesday after the company announced its Board of Directors approved a Plan of Dissolution.

    Genius Group Limited (NYSE:GNS) jumped 22.2% to $1.0750. Genius Group signed a joint venture partnership with Groove Digital Inc and Groove AI to deliver artificial-intelligence powered tools to GeniusU partners and faculty.

    Novo Integrated Sciences, Inc. (NASDAQ:NVOS) gained 22% to $0.3047.

    eHealth, Inc. (NASDAQ:EHTH) gained 20.1% to $8.07. eHealth Form 4 filing showed Director Dale B Wolf bought 15,000 shares at an average price of $7.05.

    Asset Entities Inc. (NASDAQ:ASST) jumped 19.4% to $0.64.

    Atara Biotherapeutics, Inc. (NASDAQ:ATRA) rose 17.7% to $1.8606. Atara Biotherapeutics announced plans to submit Tab-cel BLA in the second quarter of 2024 following FDA agreement on comparability.

    EBET, Inc. (NASDAQ:EBET) shares gained 16.7% to $0.0618.

    Azul S.A. (NYSE:AZUL) jumped 12.8% to $9.33. Goldman Sachs upgraded Azul from Neutral to Buy and raised the price target from $14.9 to $18.3.

    The Hain Celestial Group, Inc. (NASDAQ:HAIN) jumped 9% to $10.60.

    Gol Linhas Aéreas Inteligentes S.A. (NYSE:GOL) gained 8.3% to $2.9350 as the company disclosed preliminary traffic figures for August.

    Losers

    Seelos Therapeutics, Inc. (NASDAQ:SEEL) shares fell 75.2% to $0.2477 after the company announced its SLS-002 Phase II study did not meet the pre-defined primary endpoint due to limited sample size.

    ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) fell 55.1% to $2.9650. The FDA issued a Complete Response Letter regarding ARS Pharmaceuticals’ New Drug Application (NDA) for neffy (epinephrine nasal spray) in the treatment of Allergic Reactions (Type I), including anaphylaxis (fatal allergic reaction) for adults and children ≥30 kg.

    Connexa Sports Technologies Inc. (NASDAQ:CNXA) shares fell 40% to $0.1181 after jumping 160% on Tuesday.

    Molekule Group, Inc. (NASDAQ:MKUL) fell 37.6% to $0.4589. Molekule Group said board authorized the company’s management to commence preparation of voluntary petition under Chapter 11 of the U.S. Bankruptcy Code.

    IceCure Medical Ltd (NASDAQ:ICCM) fell 36.6% to $0.57 after the company announced the FDA has at this time denied its De Novo Classification request for breast cancer which was submitted based on interim analysis from its ICE3 study.

    QuantaSing Group Limited (NASDAQ:QSG) declined 36.4% to $3.47.

    Bird Global, Inc. (NYSE:BRDS) shares fell 32.2% to $0.97. Bird Global shares jumped more than 103% on Tuesday after the company announced its purchase of micromobility operator Skinny Labs for $19 million.

    Gorilla Technology Group Inc. (NASDAQ:GRRR) declined 24.6% to $1.07. Gorilla announced a $25 million registered direct offering of convertible preferred stock.

    Cheche Group Inc. (NASDAQ:CCG) shares fell 22.8% to $25.00 after falling 56% on Tuesday.

    Elutia Inc. (NASDAQ:ELUT) fell 18.8% to $1.34 after jumping 33% on Tuesday. The company announced a $26 million private placement of 7,355,869 shares of common stock at $1.4275 per share.

    Cazoo Group Ltd (NYSE:CZOO) declined 16.9% to $0.8227. Cazoo announced deleveraging plan with noteholders and shareholders, enhancing financial flexibility.

    Axcella Health Inc. (NASDAQ:AXLA) declined 16.6% to $10.13. The company recently announced 1-for-25 reverse stock split.

    TD Holdings, Inc. (NASDAQ:GLG) fell 12.6% to $0.1510 after gaining 7% on Tuesday.

    CSP Inc. (NASDAQ:CSPI) fell 12.6% to $17.13.

    Calidi Biotherapeutics, Inc. (NASDAQ:CLDI) fell 10.1% to $3.04.

    ImmunityBio, Inc. (NASDAQ:IBRX) tumbled 9.2% to $1.6250.

    Neumora Therapeutics, Inc. (NASDAQ:NMRA) shares fell 8% to $11.02.

    Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) fell 7.4% to $9.97.

    BeiGene, Ltd. (NASDAQ:BGNE) fell 7.2% to $193.86. B of A Securities analyst David Li maintained BeiGene with a Neutral and lowered the price target from $224.13 to $212.

    Color Star Technology Co., Ltd. (NASDAQ:ADD) declined 7% to $1.4599.

    Now Read This: Top 4 Financial Stocks That May Fall Off A Cliff

    Get the next $ADD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADD
    $AGRI
    $ASST
    $ATRA

    CompanyDatePrice TargetRatingAnalyst
    Strive Inc.
    $ASST
    4/21/2026$36.00Buy
    H.C. Wainwright
    Strive Inc.
    $ASST
    4/10/2026$26.00Buy
    TD Cowen
    ARS Pharmaceuticals Inc.
    $SPRY
    4/9/2026$25.00Outperform
    Northland Capital
    Hain Celestial Group Inc.
    $HAIN
    4/9/2026Outperform → Mkt Perform
    William Blair
    Hain Celestial Group Inc.
    $HAIN
    3/16/2026$0.50Equal Weight → Underweight
    Barclays
    ImmunityBio Inc.
    $IBRX
    3/12/2026$13.00Buy
    BTIG Research
    Strive Inc.
    $ASST
    3/10/2026$12.00Buy
    B. Riley Securities
    eHealth Inc.
    $EHTH
    2/26/2026$2.00Buy → Hold
    Craig Hallum
    More analyst ratings

    $ADD
    $AGRI
    $ASST
    $ATRA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026

    Pre-randomization Atrioventricular Interval Modulation Therapy ("AVIM Therapy") set-up data from the MODERATO II randomized, prospective, multi-center, double-blind, controlled trial show an immediate average reduction of 13.2 mmHg in office systolic blood pressure ("oSBP")97% of patients experienced an immediate blood pressure reduction of >5 mmHg reduction in oSBP prior to randomizationAVIM Therapy demonstrated the potential to deliver immediate, substantial, and sustained reductions in blood pressure, with evidence of improved diastolic function and reverse cardiac remodelingThe BACKBEAT Global Pivotal Trial, which Orchestra BioMed is actively enrolling as part of a strategic collaboratio

    4/23/26 12:00:00 PM ET
    $MDT
    $OBIO
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Medicinal Chemicals and Botanical Products

    Genius Group Identifies 30.1 Million Shares to be retired and removed from Public Float.

    The 30.1 Million Shares from the Company's ERL Share Count Exercise and ICC Arbitration Win is equivalent to 25.8% of the Company's Public Float. SINGAPORE, April 23, 2026 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE:GNS) ("Genius Group" or the "Company"), a leading AI-powered education group, today announced that further to completion of its ERL Share Count Exercise and the Company's recently announced ICC Arbitration Win, it has identified a combined 30.1 million shares of Company common stock that it plans to move into trust or treasury, with the intention to permanently retire and remove them from its public float. All 30.1 million shares are currently held by its transfer agent, VS

    4/23/26 9:15:00 AM ET
    $GNS
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    eHealth, Inc. to Hold First Quarter 2026 Earnings Call on May 6 at 5:00 p.m. Eastern Time

    INDIANAPOLIS, April 22, 2026 /PRNewswire/ -- eHealth, Inc. (NASDAQ:EHTH), a leading private online health insurance marketplace, today announced that the company plans to release first quarter 2026 financial results on May 6, 2026.The company will hold an earnings conference call beginning at 5:00 p.m. Eastern Time on May 6th to discuss these results. The call will be hosted by eHealth's chief executive officer, Derrick Duke, and eHealth's chief financial officer, John Dolan.Individuals interested in listening to the conference call may do so by dialing (833) 461-5787. The participant passcode is 615629308.A live webcast of the earnings call will be available under "Events & Presentations" o

    4/22/26 4:15:00 PM ET
    $EHTH
    Specialty Insurers
    Finance

    $ADD
    $AGRI
    $ASST
    $ATRA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    H.C. Wainwright initiated coverage on Strive with a new price target

    H.C. Wainwright initiated coverage of Strive with a rating of Buy and set a new price target of $36.00

    4/21/26 7:35:41 AM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    TD Cowen initiated coverage on Strive with a new price target

    TD Cowen initiated coverage of Strive with a rating of Buy and set a new price target of $26.00

    4/10/26 8:35:32 AM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    Northland Capital initiated coverage on ARS Pharmaceuticals with a new price target

    Northland Capital initiated coverage of ARS Pharmaceuticals with a rating of Outperform and set a new price target of $25.00

    4/9/26 8:40:24 AM ET
    $SPRY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADD
    $AGRI
    $ASST
    $ATRA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Hochman David P bought $42,900 worth of shares (10,000 units at $4.29), increasing direct ownership by 0.93% to 1,086,467 units (SEC Form 4)

    4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)

    3/16/26 4:54:18 PM ET
    $OBIO
    Medicinal Chemicals and Botanical Products
    Health Care

    Large owner Nerges Joseph R bought $18,774 worth of shares (2,207 units at $8.51), increasing direct ownership by 0.16% to 1,411,282 units (SEC Form 4)

    4 - CSP INC /MA/ (0000356037) (Issuer)

    3/13/26 2:43:24 PM ET
    $CSPI
    EDP Services
    Technology

    Chief Financial Officer Dolan John Joseph bought $38,190 worth of shares (25,000 units at $1.53), increasing direct ownership by 14% to 208,755 units (SEC Form 4)

    4 - eHealth, Inc. (0001333493) (Issuer)

    3/9/26 4:03:37 PM ET
    $EHTH
    Specialty Insurers
    Finance

    $ADD
    $AGRI
    $ASST
    $ATRA
    SEC Filings

    View All

    SEC Form 6-K filed by IceCure Medical Ltd.

    6-K - IceCure Medical Ltd. (0001584371) (Filer)

    4/22/26 5:28:16 PM ET
    $ICCM
    Medical/Dental Instruments
    Health Care

    SEC Form 6-K filed by Genius Group Limited

    6-K - Genius Group Ltd (0001847806) (Filer)

    4/22/26 5:25:33 PM ET
    $GNS
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    SEC Form DEFA14A filed by Elutia Inc.

    DEFA14A - ELUTIA INC. (0001708527) (Filer)

    4/22/26 5:02:07 PM ET
    $ELUT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADD
    $AGRI
    $ASST
    $ATRA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Medeiros Evan S

    4 - Gorilla Technology Group Inc. (0001903145) (Issuer)

    4/16/26 11:10:44 AM ET
    $GRRR
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Azeri Ismail

    4 - CSP INC /MA/ (0000356037) (Issuer)

    4/15/26 4:38:04 PM ET
    $CSPI
    EDP Services
    Technology

    SEC Form 4 filed by Barbeau Michelle Marie

    4 - eHealth, Inc. (0001333493) (Issuer)

    4/14/26 4:10:22 PM ET
    $EHTH
    Specialty Insurers
    Finance

    $ADD
    $AGRI
    $ASST
    $ATRA
    Leadership Updates

    Live Leadership Updates

    View All

    Gorilla Technology Increases Strategic Investment in Astrikos.AI

    - Builds on Q4 investment to further advance Gorilla's integrated AI infrastructure strategy across India, USA, and UAE- Appoints Managing Partner of Gorilla Tech Capital to the board of AstrikosLondon, United Kingdom--(Newsfile Corp. - April 15, 2026) - Gorilla Technology Group Inc. (NASDAQ:GRRR) ("Gorilla" or the "Company"), a global solution provider in AI-driven Security Intelligence, Network Intelligence, Business Intelligence and IoT technology, today announced that it has increased its strategic investment in Astrikos.AI ("Astrikos"), the Bengaluru, India-based, real-time infrastructure intelligence company, deepening the operational and commercial relationship betw

    4/15/26 8:30:00 AM ET
    $GRRR
    Computer Software: Prepackaged Software
    Technology

    IceCure Appoints Meir Peleg as Chief Financial Officer

    Meir Peleg brings over 20 years of financial leadership and experience including with Nasdaq listed companiesIceCure intends to appoint Dr. Richard Fine as Medical Director CAESAREA, Israel, March 24, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ:ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, today announced the appointment of Mr. Meir Peleg as its Chief Financial Officer ("CFO"), effective May 17, 2026. The appointment comes as IceCure is

    3/24/26 8:30:00 AM ET
    $ICCM
    Medical/Dental Instruments
    Health Care

    Elutia Selects Pete Ligotti as CCO to Lead the Commercial Launch of NXT-41x and Transform Post-Mastectomy Care in the $1.5B U.S. Breast Surgery Market

    GAITHERSBURG, Md., March 02, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (NASDAQ:ELUT) ("Elutia" or the "Company"), a pioneer in drug-eluting biomatrix technologies, today announced the appointment of Pete Ligotti as Chief Commercial Officer. Mr. Ligotti will lead the commercialization for NXT-41x, Elutia's next-generation antibiotic-eluting biomatrix being developed to improve outcomes in plastic and reconstructive surgery. NXT-41x is Elutia's next-generation antibiotic-eluting biomatrix, built on the Company's validated drug-eluting platform. Elutia is applying that platform in plastic and reconstructive surgery, where breast reconstruction represents the largest and most underserved opportuni

    3/2/26 8:00:00 AM ET
    $ELUT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADD
    $AGRI
    $ASST
    $ATRA
    Financials

    Live finance-specific insights

    View All

    eHealth, Inc. to Hold First Quarter 2026 Earnings Call on May 6 at 5:00 p.m. Eastern Time

    INDIANAPOLIS, April 22, 2026 /PRNewswire/ -- eHealth, Inc. (NASDAQ:EHTH), a leading private online health insurance marketplace, today announced that the company plans to release first quarter 2026 financial results on May 6, 2026.The company will hold an earnings conference call beginning at 5:00 p.m. Eastern Time on May 6th to discuss these results. The call will be hosted by eHealth's chief executive officer, Derrick Duke, and eHealth's chief financial officer, John Dolan.Individuals interested in listening to the conference call may do so by dialing (833) 461-5787. The participant passcode is 615629308.A live webcast of the earnings call will be available under "Events & Presentations" o

    4/22/26 4:15:00 PM ET
    $EHTH
    Specialty Insurers
    Finance

    IceCure Participates in Society of Breast Imaging Symposium 2026 as U.S. ProSense® Revenue Increases by 30%+ in First Quarter of 2026 Compared to First Quarter of 2025

    The Company's participation at the Society of Breast Imaging Symposium and other upcoming medical conferences are timely as commercial momentum acceleratesCryoablation cost analysis study from Massachusetts General Hospital featuring ProSense® demonstrated 50% reduction in cost vs. lumpectomy won SBI 2026 Abstract AwardCAESAREA, Israel, April 21, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ:ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, today announced that it expects to report U.S. revenue of ProSense® systems and cryoprobes increased more than 30% in

    4/21/26 8:30:00 AM ET
    $ICCM
    Medical/Dental Instruments
    Health Care

    Hain Celestial Announces Fiscal 2026 Third Quarter Earnings Results Conference Call and Webcast

    HOBOKEN, N.J., April 20, 2026 (GLOBE NEWSWIRE) -- The Hain Celestial Group, Inc. (NASDAQ:HAIN), a leading global health and wellness company whose purpose is to inspire healthier living through better-for-you brands, will release its fiscal third quarter financial results before the market opens on Monday, May 11, 2026. The company will host a conference call, which will be webcast, to discuss the results at 8:00 AM ET. The webcast and accompanying presentation will be available under the Investors section of the company's corporate website at www.hain.com. Investors and analysts can access the conference call by dialing (800) 715-9871 or (646) 307-1963 and referencing conference ID: 5099

    4/20/26 4:05:00 PM ET
    $HAIN
    Packaged Foods
    Consumer Staples

    $ADD
    $AGRI
    $ASST
    $ATRA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by MSP Recovery Inc.

    SC 13D/A - MSP Recovery, Inc. (0001802450) (Subject)

    12/17/24 4:05:04 PM ET
    $LIFW
    EDP Services
    Technology

    Amendment: SEC Form SC 13D/A filed by BeiGene Ltd.

    SC 13D/A - BeiGene, Ltd. (0001651308) (Subject)

    12/10/24 9:30:34 PM ET
    $BGNE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Gorilla Technology Group Inc.

    SC 13G/A - Gorilla Technology Group Inc. (0001903145) (Subject)

    12/6/24 9:25:12 PM ET
    $GRRR
    Computer Software: Prepackaged Software
    Technology